Formulations and methods for vascular permeability-related diseases or conditions

Details for Australian Patent Application No. 2007230964 (hide)

Owner Santen Pharmaceutical Co., Ltd.

Inventors Gerritsen, Mary; Weber, David A.; Nivaggioli, Thierry; Kleinman, David M.

Agent Spruson & Ferguson

Pub. Number AU-B-2007230964

PCT Pub. Number WO2007/112052

Priority 60/785,814 23.03.06 US

Filing date 23 March 2007

Wipo publication date 4 October 2007

Acceptance publication date 19 July 2012

International Classifications

A61K 31/436

A61P 7/10 Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

A61P 27/02 Drugs for disorders of the senses

A61P 31/16 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 Drugs for specific purposes, not provided for in groups

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/112052 Priority application(s): WO2007/112052

6 January 2011 Assignment before Grant

  Macusight, Inc. The application has been assigned to Santen Pharmaceutical Co., Ltd.

19 July 2012 Application Accepted

  Published as AU-B-2007230964

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007230967-Apolipoprotein fingerprinting technique

2007230948-Modified macrophage migration inhibitory factor inhibitors